[General therapeutic guidelines for the drug therapy of sequelae in cerebral artery occlusion].
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000188:drug therapy*; D002415:Cats; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D004285:Dogs; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007427:Intracranial Pressure; D002546:Ischemic Attack, Transient / Q000188:drug therapy
D000925:Anticoagulants; D000959:Antihypertensive Agents
Allgemeine Behandlungsrichtlinien einer medikamentösen Therapie der Hirarterienverschlussfolgen.